Insulin Prices Could Be Much Lower and Drug Makers Would Still Make Healthy Profits

If you or someone you know is struggling to pay for your lifesaving insulin, a new study suggests that insulin costs could be rolled back considerably, and manufacturers would still make a respectable profit, Stat reports. In dollars and cents, this means that Type 1 diabetics should be able to pay under $100 year for all the insulin they need — as opposed to the $1,251 you’re paying now if you live in the U.S. You may remember the pricing fiasco with lifesaving EpiPens,...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports